Affecting more than 4 million Australians, the rapid and continuing rise of allergic diseases is a serious public health issue that requires action by all levels of government and the community. To address these issues, the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), as the leading medical and patient organisations for allergy in Australia, have developed the first National Allergy Strategy for Australia, in collaboration with other stakeholder organisations. An important guiding principle is to be patient and consumer focused, and this is reflected in the Mission of the National Allergy Strategy:To improve the health and quality of life of Australians with allergic diseases, and minimise the burden of allergic diseases on individuals, their carers, healthcare services and the community.